Get breaking news alerts via email

Click here to manage your alerts
GameStop CEO treated for cancerous brain tumor
First Published Aug 19 2014 08:54 am • Last Updated Aug 19 2014 08:54 am

New York • GameStop Corp. said CEO Paul Raines had surgery last week to remove a cancerous brain tumor.

The video game retailer said the tumor was found early and doctors believe his prognosis for a full recovery is very good.

Join the Discussion
Post a Comment

Raines, who is 49, now will undergo chemotherapy, which is expected to take about six weeks.

The Grapevine, Texas company said Raines will restrict travel during that period, but the treatment should not interfere with his job. He was named CEO in June 2010.

Copyright 2014 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Top Reader Comments Read All Comments Post a Comment
Click here to read all comments   Click here to post a comment

About Reader Comments

Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
Staying Connected
Contests and Promotions
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Access your e-Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.